With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

The biotech’s initial focus is on programmes against targets that are already validated by blockbuster biologic drugs to ...

Proteins are the foundation of all life we currently know. With their virtually limitless diversity, they can perform a broad ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

Germany's biologics market, the largest in Europe, is expected to grow at a 3.8% CAGR from 2025 to 2035. AI is driving this growth by enhancing R&D, optimizing drug design, and identifying novel ...

Scientists develop DNA nanorobots capable of modifying artificial cells. Scientists at the University of Stuttgart have ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

Kadcyla contains the active ingredient ado-trastuzumab emtansine, and it’s available only as a brand-name biologic drug. It doesn’t come in a biosimilar version. A biosimilar medication is a ...

Adalimumab and secukinumab are the only FDA-approved biologic drugs to treat hidradenitis suppurativa, limiting options for ...

FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support ...